Egis World
Egis´ products are sold to more than 100 countries.

Csaba Poroszlai is CEO of Egis Pharmaceuticals PLC
Csaba Poroszlai is confirmed CEO of the company by the Board of Directors of Egis. Balázs Vándor is appointed to the position of the Company’s Chief Financial Officer. More

Egis Pharmaceuticals Plc. and the University of Szeged Expand Their Cooperation

A new educational unit named the SZTE-Egis Industrial Partnership Department will begin operations at the Faculty of Pharmacy of the University of Szeged (SZTE). Egis and the University of Szeged have already successfully collaborated in several areas as strategic partners, and the launch of the new department marks a milestone in their joint work. The agreement was ceremoniously signed on March 5, 2025, in Budapest, at the Egis Science and Technology Center. More

Agreement for Biosimilar Candidates in Key Central and Eastern European Markets

• mAbxience and Egis collaborate on the commercialization of two biosimilar candidates • The agreement covers eight Central and Eastern European countries with the potential for expansion into additional territories • mAbxience will serve as the marketing authorization holder, while Egis will manage commercialization in the designated regions More

This was the year we commemorated the 110th anniversary of the foundation of our company

Continuous modernisations and investment, launch of a new line of business, tree planting, exhibitions, and a short story contest. In 2023 Egis commemorated its 110th anniversary with a special series of events.

More

Collaboration agreement signed between Egis and the Uzbek Medicines Authority

Egis and the Uzbek Medicines Authority have signed a collaboration agreement in Tashkent to improve pharmaceutical regulations and access to medicines in Uzbekistan.

More

Dr Csaba Pácz confirmed as Commercial Director of Egis Group

The selection process for the position of Egis Group’s Commercial Director has been closed. As a result, dr Csaba Pácz remains head of the Commercial Directorate.

More

Egis Pharmaceuticals PLC for Ukraine

Since the very beginning of the war in Ukraine, Egis Pharmaceuticals PLC has been committed to helping and supporting those in need in all possible ways.

More
Other channels
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
Innovation
One of the fundamental pillars of our strategy is innovation.
Events
Our highlighted past and future events you shouldn't miss
Quick news

Cooperation with the experts of Budapest University of Technology and Economics

Apr. 29.
More

When creative minds meet

Apr. 24.
More

A Journey to the Empire of Health

Apr. 10.
More

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox